Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient

被引：0
|
作者：
A. N. Aravindan
Venkatesh Moger
Vinay Sakhuja
Harbir S. Kohli
Neelam Varma
Vivekanand Jha
机构：
[1] Postgraduate Institute of Medical Education and Research,Departments of Nephrology
[2] Hematology,undefined
[3] Postgraduate Institute of Medical Education and Research,undefined
来源：
International Urology and Nephrology | 2006年 / 38卷
关键词：
Kidney transplantation; Posttransplant lymphoproliferative disorder; Hepatitis C; Immunosuppression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Posttransplant lymphoproliferative disorders (PTLD) are commonly caused by Ebstein-Barr Virus infection. The role of hepatitis C virus (HCV) in the genesis of lymphomas has been recognized recently. We report a HCV infected renal transplant recipient who developed PTLD 11 months after transplantation. Reduction of immunosuppression led to disappearance of viremia and clearance of PTLD. This is the first such report in the world literature.
引用
收藏
页码：355 / 357
页数：2
相关论文
共 50 条
  • [1] Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient
    Aravindan, A. N.
    Moger, Venkatesh
    Sakhuja, Vinay
    Kohli, Harbir S.
    Varma, Neelam
    Jha, Vivekanand
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2006, 38 (02) : 355 - 357
  • [2] Posttransplant Lymphoproliferative Disorder With Lung Involvement in a Renal Transplant Recipient
    Mirza, Emel Isiktas
    Mutluay, Ruya
    Suyani, Elif
    Okyay, Gulay Ulusal
    Akyurek, Nalan
    Aki, Sahika Zeynep
    Derici, Ulver
    Arinsoy, Turgay
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (06) : 425 - 428
  • [3] Post-Transplant Lymphoproliferative Disorder in a Kidney Transplant Recipient
    Agarwal, Gaurav
    Mannon, Roslyn B.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (05): : 751 - 753
  • [4] Fibrosing cholestatic hepatitis in a kidney transplant recipient with hepatitis C virus
    Takahiro Shinzato
    Taro Kubo
    Toshihiro Shimizu
    Koji Nanmoku
    Takashi Yagisawa
    CEN Case Reports, 2019, 8 : 101 - 105
  • [5] Fibrosing cholestatic hepatitis in a kidney transplant recipient with hepatitis C virus
    Shinzato, Takahiro
    Kubo, Taro
    Shimizu, Toshihiro
    Nanmoku, Koji
    Yagisawa, Takashi
    CEN CASE REPORTS, 2019, 8 (02) : 101 - 105
  • [6] Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes
    Cohen, Jordana B.
    Eddinger, Kevin C.
    Shelton, Brittany
    Locke, Jayme E.
    Forde, Kimberly A.
    Sawinski, Deirdre
    CLINICAL KIDNEY JOURNAL, 2017, 10 (04) : 564 - 572
  • [7] Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epstein-Barr virus infection
    Hori, T.
    Oike, F.
    Hata, K.
    Nishikiori, M.
    Ogura, Y.
    Ogawa, K.
    Takada, Y.
    Egawa, H.
    Nguyen, J. H.
    Uemoto, S.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (04) : 347 - 352
  • [8] Mixed cryoglobulinaemia and hepatitis C virus: a paradigm of a virus-related autoimmune and lymphoproliferative disorder
    Ferri, C.
    Bombardieri, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (06) : 1265 - 1268
  • [9] A Solid Mass in the Chest Wall: An Unusual Presentation of Posttransplant Lymphoproliferative Disorder in a Renal Transplant Recipient
    Alagoz, Selma
    Yalin, Serkan Feyyaz
    Gulcicek, Sibel
    Ozgur, Nurgul
    Altiparmak, Mehmet Riza
    Seyahi, Nurhan
    PROGRESS IN TRANSPLANTATION, 2016, 26 (04) : 386 - 388
  • [10] Posttransplant lymphoproliferative disorder in a lung transplant recipient
    Tamai, K
    Koyama, T
    Saga, T
    Umeoka, S
    Aoyama, A
    Hanaoka, N
    Fukuse, T
    Wada, H
    Tachibana, M
    Togashi, K
    JOURNAL OF THORACIC IMAGING, 2005, 20 (04) : 280 - 283
12345